Company news
Cormedix Inc. (NASDAQ:CRMD) news
Every Cormedix Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Cormedix Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
August 13, 2026
CorMedix Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 13, 2026
July 29, 2026
CervoMed Announces New Clinical, Plasma Biomarker and Imaging Data at AAIC 2026 for Neflamapimod in the Treatment of Dementia with Lewy B...
July 14, 2026
U.S. Court of Appeals for the Federal Circuit Affirms Victory for Cormedix Therapeutics in Minocin® Patent Litigation
June 8, 2026
Cormedix Therapeutics to Participate in two Upcoming Investor Conferences
May 15, 2026
Cormedix Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
May 14, 2026
CorMedix Therapeutics to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 14, 2026
May 5, 2026
CorMedix Therapeutics Announces Positive Topline Results from Phase III ReSPECT Trial Assessing REZZAYO® for the Prophylaxis of Invasive ...
April 27, 2026
CorMedix to Participate in Needham Virtual Healthcare Conference
April 7, 2026
CorMedix Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
March 5, 2026
CorMedix Inc. to Report Fourth Quarter and Full Year 2025 Financial Results and Provide a Corporate Update on March 5, 2026
March 2, 2026
CorMedix Therapeutics Announces Share Repurchase Program
February 2, 2026
CorMedix Therapeutics to Host In-Person and Virtual Analyst Day in New York on February 10, 2026
January 29, 2026
CorMedix Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 9, 2026
CorMedix Therapeutics Announces Leadership and Board Updates
January 8, 2026
CorMedix Therapeutics Announces Preliminary Fourth Quarter and Full Year 2025 Results and Provides Business Updates
January 8, 2026
CorMedix Therapeutics Announces Positive Data From Ongoing Real World Evidence Study of DefenCath
December 18, 2025
CorMedix Inc. Reports Third Quarter 2025 Financial Results and Updates FY 2025 Guidance
November 12, 2025
Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update
November 12, 2025
CorMedix Inc. to Report Third Quarter 2025 Financial Results and Provide a Corporate Update on November 12, 2025
October 31, 2025
CorMedix Inc. Receives Innovative Technology Designation From Vizient for DefenCath
October 23, 2025
Talphera Announces the Appointment of Joe Todisco to Board of Directors
October 21, 2025
CorMedix Inc. Announces Preliminary Third Quarter 2025 Results and Raises 2025 Net Revenue Guidance
October 20, 2025
CorMedix Announces Completion of Enrollment in Phase III ReSPECT Clinical Trial for REZZAYO
September 29, 2025
Talphera Announces Private Placement Financing of up to $29 Million Priced At-the Market
September 8, 2025
CorMedix Announces Strategic Minority Investment in Talphera
September 8, 2025
Deerfield Management Announces Sale of Melinta Therapeutics
September 5, 2025
CorMedix Completes Acquisition of Melinta Therapeutics, Raises Financial Guidance and Announces New Leadership Team
September 2, 2025
CorMedix to Participate in Upcoming Investor Conferences
August 28, 2025
Cormedix Inc. Reports Second Quarter 2025 Financial Results and Provides Business Update
August 7, 2025
CorMedix to acquire Melinta Therapeutics, Creating Diversified Specialty Company With Strong Presence in Acute Care Settings
August 7, 2025
Melinta Therapeutics Announces Strategic Acquisition by CorMedix, Underscoring Its Portfolio Value and Industry Leadership
August 7, 2025
CorMedix Inc. Announces Pricing of Public Offering of Common Stock
June 27, 2025
CorMedix Inc. Announces Proposed Public Offering of Common Stock
June 26, 2025
CorMedix inc. Announces Customer Implementation
June 23, 2025
CorMedix Inc. To Participate In The Jefferies Global Healthcare Conference
May 30, 2025
CorMedix Inc. to Participate in the RBC Global Healthcare Conference
May 15, 2025
CorMedix Inc. Reports First Quarter 2025 Financial Results and Provides Business Update
May 6, 2025
CorMedix Inc. to Report First Quarter 2025 Financial Results and Provide a Corporate Update on May 6, 2025
April 29, 2025
Cormedix Inc. Announces Preliminary First Quarter 2025 Results and Raises H1 2025 Net Sales Guidance
April 8, 2025
CorMedix Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference
April 2, 2025
CorMedix Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
March 25, 2025
CorMedix Inc. to Report Fourth Quarter and Full Year 2024 Financial Results and Provide a Corporate Update on March 25, 2025
March 18, 2025
CorMedix Announces Collaboration for DefenCath Promotion to the VA and Other Federal Facilities
January 21, 2025
CorMedix Inc. Announces Preliminary Fourth Quarter 2024 Results and Provides Business Update
January 7, 2025
CorMedix Inc. Added to Nasdaq Biotechnology Index
December 19, 2024
CorMedix Inc. Supports CMS Policy Updates Regarding Access to Innovative Drug Products
November 26, 2024
CorMedix Inc. to Participate in the Truist Securities BioPharma Symposium
November 4, 2024
CorMedix Inc. Reports Third Quarter and Nine Month 2024 Financial Results and Provides Business Update
October 30, 2024
CorMedix Inc. Announces New Data at ASN Kidney Week 2024
October 24, 2024